Sarepta Therapeutics Inc.

08/04/2021 | Press release | Distributed by Public on 08/04/2021 06:33

Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Children’s Hospital to Treat Limb-Girdle Muscular Dystrophy Type 2A